This test is most useful if any of these apply to you.
Two people can walk in with identical cholesterol numbers and leave with very different odds of a heart attack. What often separates them is how many ApoB-carrying particles are in their blood. This test tracks that count.
That count is the clearest lipid signal of whether particles are available to enter artery walls, the process behind most heart attacks and many strokes. It can catch risk that a standard cholesterol panel misses.
The marker is ApoB (apolipoprotein B), measured from a blood sample. LDL, VLDL, IDL, lipoprotein(a), and chylomicron remnants each carry one ApoB molecule. Most ApoB in a routine result is ApoB-100 from liver-made particles. A smaller share is ApoB-48 from intestine-made particles, and routine assays do not separate the two.
So your ApoB level is a close headcount of artery-damaging particles, not a measure of how much cholesterol is riding inside them. A standard LDL cholesterol result tells you the cholesterol packed into LDL particles. It does not tell you how many particles are doing the packing.
Across genetic studies, large cohorts, and treatment trials, ApoB tracks future heart attacks more tightly than cholesterol content does.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 430,000 adults, with and without existing heart disease | ApoB versus cholesterol content and particle type | ApoB was the best independent lipid predictor of heart attack |
| About 207,000 adults without known atherosclerosis, diabetes, or lipid-lowering therapy | ApoB particle count versus particle type and size | A higher count meant about a third more coronary artery disease |
| About 184,000 people in a coronary disease genetics dataset | Inherited differences linked to ApoB, LDL cholesterol, and triglycerides | ApoB carried the main lipid-related genetic signal for coronary risk |
Source: Marston et al. (JAMA Cardiology, 2021); Morze et al. (European Heart Journal, 2025); Richardson et al. (PLoS Medicine, 2020).
What this means for you: when ApoB and cholesterol numbers point in different directions, ApoB is usually the better lipid signal. If it is high, the particles it counts are worth bringing down, even if LDL cholesterol looks acceptable.
An LDL cholesterol result can look reassuring while ApoB tells a different story. In one analysis of people with very low LDL cholesterol, about 40% had ApoB that was higher than their LDL cholesterol suggested. They had more particles than the LDL number implied.
This gap shows up most in people with high triglycerides, diabetes, extra weight, or insulin resistance, where particles tend to be small and cholesterol-poor. In one Korean adult screening study, adding ApoB to routine lipid criteria raised the share flagged with a lipid problem from about 27% to about 45%, and roughly 1 in 6 had high ApoB while routine cholesterol looked reassuring.
If you have type 2 diabetes or insulin resistance, LDL cholesterol can look fine while particle count runs high. In one UK Biobank cohort of people with type 2 diabetes, higher ApoB was linked to more cardiovascular events. Excess ApoB sharpened that risk picture further. Excess ApoB compares your measured ApoB with what would be expected from LDL cholesterol alone.
A similar pattern shows up in fatty liver disease. In one observational study of children and teens with obesity, those in the top few percent of ApoB had nearly five times the odds of metabolic fatty liver disease compared with those in the middle of the range.
Higher ApoB reliably predicts more heart attacks, but its link to overall death is messier. In some studies of people who already have advanced coronary disease, lower ApoB was paired with higher death rates, which sounds backwards.
That pattern is mostly a warning about the people being studied. In advanced coronary disease, low ApoB can travel with malnutrition, liver trouble, and other illness. Those things raise death rates and can also lower cholesterol-carrying proteins. In prevention screening, the practical read is simpler: more ApoB particles means more cardiovascular risk. Genetic evidence backs that up: people who inherit higher ApoB develop more coronary disease, not less, so the backwards pattern in already-sick patients reflects their illness rather than any protection from having fewer particles. ApoB is a marker of particle burden, not a standalone predictor of when you will die.
ApoB is a stable, well-standardized blood measurement with relatively little day-to-day fluctuation, which makes it well suited to tracking over time. A single value tells you where you stand today. A trend tells you whether your risk is drifting up as you age or coming down in response to what you are doing about it.
Use repeat testing when you change something that should lower ApoB, such as diet, weight, or lipid-lowering medication. The trend tells you whether the plan moved the particle burden.
The most useful readings are the discordant ones, where ApoB and cholesterol disagree. If ApoB is high while LDL looks fine, treat ApoB as the truer lipid signal and look at what is driving it: check triglycerides, fasting glucose, HbA1c, and blood pressure for a metabolic pattern. HbA1c shows your average blood sugar over the past few months. Measure lipoprotein(a) at least once, since those particles carry ApoB too but add their own inherited risk.
hs-CRP is a blood test for low-grade inflammation. Pairing it with ApoB can help separate particle burden from inflammatory risk, since both can push plaque forward through different routes. If ApoB stays high despite lifestyle changes, or you have a family history of early heart disease, use the full pattern to decide whether lifestyle alone is enough or prescription lipid-lowering makes sense. If the pattern is extreme or hard to explain, a lipid specialist can help.
ApoB is more reliable than a calculated LDL cholesterol, and unlike that calculation it does not require fasting. A recent meal should not distort it. Still, a few things can make one reading unrepresentative of your usual level.
Evidence-backed interventions that affect your ApoB level
ApoB is best interpreted alongside these tests.
ApoB is included in these pre-built panels.